Nonopioid analgesics, NSAIDs recommended as first- and second-line agents for osteoarthritis

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:16 / 16
页数:1
相关论文
共 50 条
  • [1] Coronary angiography: first- or second-line examination?
    Danchin, N
    Angioi, M
    Fattah, IA
    Jacquemin, L
    ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 1997, 46 (08): : 493 - 497
  • [2] Docetaxel in the first- and second-line therapy of gastric cancer
    Vanhoefer, U
    ONKOLOGIE, 2000, 23 : 40 - 42
  • [3] First- and second-line therapy of metastatic colorectal cancer
    Terstriep, Shelby
    Grothey, Axel
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (06) : 921 - 930
  • [4] Fetal tachycardia: A role for amiodarone as first- or second-line therapy?
    Pezard, Philippe Georges
    Boussion, Francoise
    Sentilhes, Loic
    Lepinard, Catherine
    Couvreur, Marie-Helene
    Victor, Jacques
    Geslin, Philippe
    Descamps, Philippe
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2008, 101 (10) : 619 - 627
  • [5] Metastatic colorectal cancer:: First- and second-line treatment in 2005
    Rougier, P
    Lepère, C
    SEMINARS IN ONCOLOGY, 2005, 32 (06) : S15 - S20
  • [6] Interferon Alfa as a First- and Second-Line Treatment Option for Primary Myelofibrosis
    Sghibneva-Bobeico, Nina
    Musteata, Vasile
    Robu, Maria
    Covalschi, Elena
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S391 - S391
  • [7] Prognostic Factors for Complete Debulking in First- and Second-Line Ovarian Cancer
    Harter, Philipp
    Hilpert, Felix
    Mahner, Sven
    Kommoss, Stefan
    Heitz, Florian
    Pfisterer, Jacobus
    du Bois, Andreas
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 : S14 - S17
  • [8] First- and second-line therapy for advanced nonsmall cell lung cancer
    Sculier, J-P.
    Moro-Sibilot, D.
    EUROPEAN RESPIRATORY JOURNAL, 2009, 33 (04) : 915 - 930
  • [9] Docetaxel: Efficacy in first- and second-line therapy of advanced breast cancer
    Crown, J
    ONKOLOGIE, 2000, 23 : 1 - 3
  • [10] Efficacy and safety of first- or second-line irinotecan, cisplatin, and mitomycin in mesothelioma
    Fennell, Dean A.
    Steele, Jeremy P. C.
    Shamash, Jonathan
    Evans, Marie T.
    Wells, Paula
    Sheaff, Michael T.
    Rudd, Robin M.
    Stebbing, Justin
    CANCER, 2007, 109 (01) : 93 - 99